RGBP
Price:
$0.0002
Market Cap:
$6.31K
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Industry
Biotechnology
IPO Date
2014-10-06
Stock Exchange
OTC
Ticker
RGBP
According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.05. This represents a change of 21.22% compared to the average of 0.04 of the last 4 quarters.
The mean historical Current Ratio of Regen BioPharma, Inc. over the last ten years is 0.06. The current 0.05 Current Ratio has changed 8.02% with respect to the historical average. Over the past ten years (40 quarters), RGBP's Current Ratio was at its highest in in the December 2016 quarter at 0.54. The Current Ratio was at its lowest in in the December 2019 quarter at 0.00.
Average
0.06
Median
0.03
Minimum
0.00
Maximum
0.26
Discovering the peaks and valleys of Regen BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 388.71%
Maximum Annual Current Ratio = 0.26
Minimum Annual Increase = -93.96%
Minimum Annual Current Ratio = 0.00
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.04 | 40.75% |
| 2024 | 0.03 | 20.56% |
| 2023 | 0.02 | -36.93% |
| 2022 | 0.04 | -42.13% |
| 2021 | 0.07 | 388.71% |
| 2020 | 0.01 | 92.47% |
| 2019 | 0.01 | 45.82% |
| 2018 | 0.00 | -93.96% |
| 2017 | 0.08 | -68.55% |
| 2016 | 0.26 | 32.81% |
The current Current Ratio of Regen BioPharma, Inc. (RGBP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
0.03
5-year avg
0.04
10-year avg
0.06
Regen BioPharma, Inc.’s Current Ratio is less than Innovation Pharmaceuticals Inc. (0.33), less than Viracta Therapeutics, Inc. (1.43), less than Wesana Health Holdings Inc. (0.49), greater than RespireRx Pharmaceuticals Inc. (0.00), less than Actavia Life Sciences, Inc. (0.05), less than Dental Patient Care America, Inc. (1.71), less than ChitogenX Inc. (0.07), greater than THC Farmaceuticals, Inc. (0), less than Levitee Labs Inc. (0.89), less than Nascent Biotech, Inc. (0.68),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.33 | $103.67K | |
| 1.43 | $388.70K | |
| 0.49 | $341.00K | |
| 0.00 | $657.75K | |
| 0.05 | $385.91K | |
| 1.71 | $1.12M | |
| 0.07 | $627.63K | |
| 0 | $47.14K | |
| 0.89 | $369.15K | |
| 0.68 | $68.89K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Regen BioPharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for Regen BioPharma, Inc. (RGBP)?
What is the highest Current Ratio for Regen BioPharma, Inc. (RGBP)?
What is the 3-year average Current Ratio for Regen BioPharma, Inc. (RGBP)?
What is the 5-year average Current Ratio for Regen BioPharma, Inc. (RGBP)?
How does the current Current Ratio for Regen BioPharma, Inc. (RGBP) compare to its historical average?